During the past decade, Inland Empire Liver Foundation conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 27 clinical trials were completed, i.e. on average, 47.4% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 26 clinical trials were completed. i.e. 162.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Inland Empire Liver Foundation" #1 sponsor was "Gilead Sciences" with 7 trials, followed by "Eli Lilly and Company" with 6 trials sponsored, "Intercept Pharmaceuticals" with 5 trials sponsored, "Shire" with 5 trials sponsored and "Celgene" with 5 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inland Empire Liver Foundation" #1 collaborator was "Triangle Biostatistics" with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "Insulet Corporation" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Inland Empire Liver Foundation" are "Nonalcoholic Steatohepatitis" (9 trials), "Crohn's Disease" (5 trials), "Ulcerative Colitis" (5 trials), "Non-Alcoholic Steatohepatitis" (4 trials) and "Cirrhosis" (3 trials). Many other conditions were trialed in "Inland Empire Liver Foundation" in a lesser frequency.

Most popular intervention types in "Inland Empire Liver Foundation" are "Drug" (54 trials), "Other" (8 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Ontamalimab" (4 trials), "Ozanimod" (3 trials), "SEL" (3 trials) and "Cenicriviroc" (2 trials). Other intervention names were less common.

The vast majority of trials in "Inland Empire Liver Foundation" are 59 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Inland Empire Liver Foundation". undefined are not yet recruiting, 10 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Inland Empire Liver Foundation, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Inland Empire Liver Foundation, 6 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".